This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SEEBURGER Adds Cloud-Based CSOS Option With Legisym's Express222

TAMPA, Fla., March 4, 2013 /PRNewswire/ -- Global business integration software provider SEEBURGER today announced the availability of Legisym's Express222™ cloud-based Controlled Substance Ordering System (CSOS) solution as an add-on to SEEBURGER's business integration platform for healthcare customers seeking a cost-effective CSOS solution with no software installation requirements for themselves or their trading partners. The SEEBURGER Business Integration Suite (BIS) can be delivered in tandem with Express222 as a managed service, providing an end-to-end hosted B2B and CSOS solution. Alternatively, SEEBURGER BIS can be deployed behind the corporate firewall in a private cloud or licensed scenario.

Click to Tweet:

The new partnership enables SEEBURGER customers to take advantage of the only completely Web-based CSOS solution that meets the strict DEA order management requirements for the safe and secure transport of controlled substance pharmaceuticals. Winner of the HDMA Distribution Management Award for innovation in health distribution processes, Legisym's Express222 enables suppliers of all sizes and requirements – from the occasional Class II buyer to the frequent multiple-order buyer – to eliminate the paper DEA Form 222 while also avoiding the large upfront investment, annual maintenance fees, technical complexities and extensive support needs of client/server CSOS solutions.

The joint SEEBURGER/Legisym solution is being demonstrated at SEEBURGER's Booth 204 and Legisym's  Booth 703 at this week's Healthcare Distribution Management Association (HDMA) conference  in Tampa.

Strong Customer Support

The ability to combine the SEEBURGER and Legisym solutions in a hosted environment, and avoid the time and expense of integrating the CSOS solution into the organization's B2B platform, provides an efficient, easy-to-deploy and DEA-compliant strategy for expediting the exchange of controlled substances  among manufacturers, wholesalers, pharmacies and reverse distributors. That includes the ability to leverage modern process improvements such as batch signing with POA certificate management capabilities favored by mass retailers and reverse distributors to centralize digital signing for thousands of locations.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs